Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. STRW
STRW logo

STRW Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Strawberry Fields Reit Inc (STRW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
12.000
1 Day change
0.08%
52 Week Range
14.000
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Strawberry Fields REIT (STRW) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is trading at a discount compared to its peers, has strong growth through acquisitions, and insiders are showing confidence with significant buying activity. Despite the lack of immediate trading signals and neutral technical indicators, the company's strong financial performance and positive analyst sentiment make it a solid long-term investment opportunity.

Technical Analysis

The MACD is below zero and negatively contracting, indicating a bearish trend. RSI is neutral at 37.869, and moving averages are converging, suggesting no strong directional trend. The stock is trading near its pivot point of 12.382, with support at 11.866 and resistance at 12.897.

Positive Catalysts

  • Insiders have increased buying activity by 1492.69% over the last month.

  • Analysts have raised price targets to $15-$16 and maintain Buy or Overweight ratings, citing growth through acquisitions and undervaluation compared to peers.

  • Strong financial performance with revenue up 31.51% YoY and net income up 37.56% YoY in Q4 2025.

Neutral/Negative Catalysts

  • EPS dropped by 11.76% YoY in Q4 2025, which could indicate some profitability concerns.

  • Technical indicators do not show a strong bullish signal currently.

Financial Performance

In Q4 2025, revenue increased by 31.51% YoY to $40,095,000, and net income grew by 37.56% YoY to $2,018,000. However, EPS dropped by 11.76% YoY to 0.15. Gross margin improved slightly to 83.36%, up 0.41% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are positive on STRW, with recent price target increases to $15-$16 and Buy or Overweight ratings. They highlight the company's growth through acquisitions and undervaluation compared to peers in the healthcare REIT sector.

Wall Street analysts forecast STRW stock price to rise
4 Analyst Rating
Wall Street analysts forecast STRW stock price to rise
4 Buy
0 Hold
0 Sell
Strong Buy
Current: 11.990
sliders
Low
13
Averages
14.13
High
15
Current: 11.990
sliders
Low
13
Averages
14.13
High
15
Lake Street
Mark Smith
Buy
maintain
$16
AI Analysis
2026-02-23
Reason
Lake Street
Mark Smith
Price Target
$16
AI Analysis
2026-02-23
maintain
Buy
Reason
Lake Street analyst Mark Smith raised the firm's price target on Strawberry Fields REIT to $16 from $14.50 and keeps a Buy rating on the shares after the company reported Q4 results that were generally ahead of the firm's expectations. Strawberry Fields has proven its ability to grow through acquisition, says the analyst, who thinks there are "ample opportunities in existing states to acquire new properties and expand."
Alliance Global
Buy
maintain
$14 -> $15
2026-02-20
Reason
Alliance Global
Price Target
$14 -> $15
2026-02-20
maintain
Buy
Reason
Alliance Global raised the firm's price target on Strawberry Fields REIT to $15 from $14 and keeps a Buy rating on the shares post the Q4 report. The firm believes the company's growth through acquisitions should continue. Strawberry Fields is trading at a discount to comparable healthcare real estate investment trusts with exposure to skilled nursing, providing a risk/reward that is skewed to the upside at the current levels, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for STRW
Unlock Now

People Also Watch